Blepharoplasty Market

Blepharoplasty Market Size, Share, Growth Analysis, By Procedure Type(Upper Eyelid Surgery, Lower Eyelid Surgery), By End-user(Clinics, Hospitals), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35E2015 | Region: Global | Published Date: March, 2019
Pages: 165 | Tables: 61 | Figures: 75

Blepharoplasty Market News

  • In August 2022, Stanford medicine announced it has opened a new pediatric emergency department with a child-centered space. This is done to make children and their families comfortable while their visit to the pediatric center.
  • In December 2021, IOPtima announced a partnership with ROCOL, a distributor of medical equipment in Colombia. ROCOL is known for producing goods of the greatest quality in the fields of ophthalmology, cancer, aesthetics, and surgery.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Blepharoplasty Market size was valued at USD 3.45 billion in 2019 and is poised to grow from USD 3.71 billion in 2023 to USD 7.2 billion by 2031, growing at a CAGR of 7.6% in the forecast period (2024-2031).

The Blepharoplasty market is relatively fragmented, with a high level of competition. Few large players, like Stanford Health Care, Luminera Derm Ltd., and IOPtima Ltd., now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Allergan Inc.', 'Cutera Inc.', 'Cynosure Inc.', 'Erchonia Corporation', 'Hologic Inc.', 'Lumenis Ltd.', 'Merz Pharma GmbH & Co. KGaA', 'Nestlé Skin Health S.A.', 'Palomar Medical Technologies Inc.', 'Sciton Inc.', 'Syneron Medical Ltd.', 'Alma Lasers Ltd.', 'Bausch Health Companies Inc.', 'El.En. S.p.A.', 'Fotona d.o.o.', 'Galderma S.A.', 'InMode Ltd.', 'Lutronic Corporation', 'Solta Medical Inc.', 'Valeant Pharmaceuticals International Inc.'

The increasing prevalence of eye-related illnesses, particularly in the elderly population, is anticipated to stimulate growth. Globally, eye disorders such as droopy eyes, blurred vision, and wrinkles around the eyes are on the rise, consequently boosting the demand for blepharoplasty procedures. Ultimately, this will increase demand during the projection period. Additionally, the demand for enhanced aesthetics is driving market expansion.

The trend for blepharoplasty is fueled by the increasing desire to improve one's appearance aesthetically and the rising awareness of cosmetic operations. In addition, the increasing number of millennials, rising disposable income, and rising healthcare expenditures are significant market growth drivers.

In terms of market share, North America dominated the global blepharoplasty market in the year 2021. Due to the availability of enhanced facilities and the growing demand for cosmetic surgery among the millennial and elderly populations, the market for blepharoplasty is expanding. Moreover, the region's rapid adoption of innovative techniques and devices is driving the blepharoplasty market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Blepharoplasty Market

Report ID: SQMIG35E2015

$5,300
BUY NOW GET FREE SAMPLE